Navigation Links
A drug used to treat HIV might defuse deadly staph infections
Date:12/14/2012

A new study by NYU School of Medicine researchers suggests that an existing HIV drug called maraviroc could be a potential therapy for Staphylococcus aureus, a notorious and deadly pathogen linked to hundreds of thousands of hospitalizations each year. Their study is published online this week in Nature.

"What are the chances that a drug for HIV could possibly treat a virulent Staph infection?" asks Victor J. Torres, PhD, assistant professor of microbiology, and senior author of the study. "These findings are the result of a fantastic collaboration that we hope will result in significant clinical benefit." Staph causes toxic shock syndrome, pneumonia, and food poisoning, among other illnesses, and is becoming increasingly resistant to antibiotics.

The discovery arose from a serendipitous finding that was a part of a collaborative study between Dr. Torres, a bacteriologist, and immunologist Derya Unutmaz, MD, associate professor of microbiology and pathology and medicine, whose laboratories are adjacent to each other.

They focused on a receptor called CCR5 that dots the surface of immune T cells, macrophages, and dendritic cells. Sixteen years ago, researchers at NYU School of Medicine discovered that CCR5 is the receptor HIV uses to gain entry into T cells in order to replicate, spread, and cause an infection that can progress into AIDS.

That same receptor has now been found to be critical to the ability of certain strains of Staph to specifically target and kill cells with CCR5, which orchestrate an immune response against the bacteria. The scientists discovered that one of the toxins the bacterium releases, called LukED, latches on to CCR5 and subsequently punches holes through the membrane of immune cells, causing them to rapidly die. The LukED toxin belongs to a family of proteins called leukotoxins, encoded and produced by Staph to fight off the immune system's defenses.

This discovery was made
'/>"/>

Contact: Christopher Rucas
Christopher.Rucas@nyumc.org
212-404-3525
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Lethal stings from the Australian box jellyfish could be treated with zinc
2. Vaccine offers promise as post-surgery treatment for pancreatic cancer patients
3. TGen-US Oncology data guides treatment of metastatic triple-negative breast cancer patients
4. Nanotechnology drug delivery shows promise for treatment of pediatric cancer
5. ALS TDI and Gladstone Institutes collaborate to discover potential ALS treatments
6. Protein injection points to muscular dystrophy treatment
7. Possible new treatment for Ewing sarcoma
8. Combination of two pharmaceuticals proves effective in the treatment of multiple sclerosis
9. Notre Dame research could improve sustainability and cost effectiveness of wastewater treatment
10. Second most common infection in the US proving harder to treat with current antibiotics
11. Hormone combination effective and safe for treating obesity in mice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... powerful new tool that can help advance the ... and renewable bioenergy, has been developed by researchers ... BioEnergy Institute (JBEI), a multi-institutional partnership led by ... researchers have developed an assay that enables scientists ... sugar transporters, critical components in the biosynthesis of ...
(Date:7/28/2014)... The Wyss Institute for Biologically Inspired Engineering at ... technology will be commercialized by a newly formed ... cosmetic, and personalized medicine products. The ... Office of Technology Development (OTD) and the start-up ... Institute,s automated human Organs-on-Chips platform. , "This ...
(Date:7/27/2014)... have survived the asteroid strike that wiped them out ... in history, scientists say. , A fresh study using ... palaeontologists to build a new narrative of the prehistoric ... found that in the few million years before a ... experiencing environmental upheaval. This included extensive volcanic activity, changing ...
Breaking Biology News(10 mins):How sweet it is 2How sweet it is 3Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 2Wyss Institute's technology translation engine launches 'Organs-on-Chips' company 3Dinosaurs fell victim to perfect storm of events, study shows 2
... is part of a research team breaking new ground in ... $2.5 million grant from the National Institutes of Health, the ... for Xerostomia, or dry mouth, an inevitable consequence of radiation ... project is a collaborative effort between researchers at Rice University, ...
... Ore. Many studies have found that high levels of ... poor fitness and reduced chance of survival but recent ... be a good thing, often the difference between life and ... glucocorticoid hormones, which are part of the natural response to ...
... have identified 38 new genetic regions that are associated with ... total number of genetic regions associated with glucose and insulin ... type 2 diabetes. The researchers used a technology ... to follow-up on genome-wide association results. This technology, Metabochip, was ...
Cached Biology News:UD partner in NIH research project to produce artificial salivary glands 2UD partner in NIH research project to produce artificial salivary glands 3For young birds, getting stressed out can be a good thing 2Metabolic MAGIC 2Metabolic MAGIC 3
(Date:7/28/2014)... 2014 According to ... (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic), Applications (Pharmaceutical, Diagnostic, ... Characterization) - Global Forecasts to 2019" published ... estimated at $896.5 Million in 2014 and ... 2019, growing at a CAGR of 5.9% ...
(Date:7/28/2014)... , July 28, 2014   Propeller Health ... disease, announced the hire of Brad Towle ... will be responsible for driving the company,s sales growth, ... experience in healthcare, and specifically his past role in ... to the company at this pivotal time in the ...
(Date:7/28/2014)... San Francisco, California (PRWEB) July 28, 2014 ... reach USD 604.40 billion by 2020, according to a ... scope coupled with the rising demand for effective vaccines ... to patients with unmet medical needs is expected to ... addition, the need to enhance agricultural productivity via the ...
(Date:7/28/2014)... Research and Markets has announced the ... report to their offering. ... technique used to determine the size of a particle in ... to analyze the size of particles as it can affect ... performed to determine the behavior and nature of a material, ...
Breaking Biology Technology:Microbial Identification Market worth $1,194.1 Million by 2019 2Microbial Identification Market worth $1,194.1 Million by 2019 3Propeller Health Hires Brad Towle as Senior Vice President of Business and Client Development 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Global Particle Size Analysis Market 2014-2018 2
... Fla. , April 23 Moffitt Cancer Center announces ... for selecting chemotherapy for Non Small Lung Cancer patients.  Each year, ... , , ... ERCC1 levels in cells to predict response to cisplatin-based chemotherapy.   ...
... April 22 /PRNewswire-FirstCall/ - Dragon Pharmaceutical Inc. ("Dragon Pharma" ... a complaint regarding its proposed merger with Datong Investment Inc ... Circuit for Palm Beach County , State of ... Yanlin Han , a director and Chief Executive Officer ...
... ... role of natural resources in food production. Technologies that grow more from less improve ... (PRWEB) ... has become a founding member of the Sustainability Consortium , an independent group ...
Cached Biology Technology:Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 2Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 3Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer 4Complaint Filed Regarding Proposed Merger 2Complaint Filed Regarding Proposed Merger 3Complaint Filed Regarding Proposed Merger 4Syngenta joins Sustainability Consortium as Founding Member 2Syngenta joins Sustainability Consortium as Founding Member 3
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
... g. High quality kits and ... that give consistent and reliable ... tissues.Clean up samples from contaminants.Efficiently ... quantitate protein for first-dimension isoelectric ...
... The Varian Cary 50 ... reduces your cost per analysis ... throughput of the award-winning Cary ... analyze up to 384 samples ...
GOAT ANTI CARICA PAPAYA PAPAIN...
Biology Products: